January 9, 2026: Deadline for a joint notice designating the initial four sites for discovery under the FTCA discretionary function exception.
December 2025: Case Management Orders (CMOs) were posted governing discovery for CERCLA jurisdictional motions, scheduling for Group B personal injury bellwether trials, and establishing a phased discovery process for FTCA jurisdictional issues.
Camp Lejeune
March 12, 2026: The DOJ announced it is accelerating settlement approvals under the Camp Lejeune Justice Act for individuals exposed to contaminated water.
March 2, 2026: The plaintiffs’ leadership urged swift resolutions due to the aging and ill victim population, while the government stressed the need for finalized medical records to prepare for bellwether trials.
CPAP (Philips)
March 9, 2026: A Pennsylvania federal judge refused to reopen a product liability case against Philips, ruling the plaintiff and his attorney were responsible for monitoring the docket after they missed notifications for eight months.
January 23, 2026: A federal judge remanded a CPAP-related cancer case to Kentucky state court, rejecting arguments of improper joinder.
Depo-Provera
February 27, 2026: Defendants’ reply on preemption was due.
February 26, 2026: The Delaware Supreme Court refused to hear an interlocutory appeal, keeping Superior Court case-management orders in place.
January 23, 2026: Active trial calendars and case management conferences were underway.
January 22, 2026: A Case Management Conference took place in the MDL.
January 20, 2026: The parties’ Joint Agenda Letter was due.
January 9-10, 2026: Defendants’ general causation expert disclosures and depositions were due for Pilot Cases.
December 19, 2026: A Case Management Conference was scheduled.
December 18, 2026: The FDA approved an updated label adding a brain tumor (meningioma) warning to Depo-Provera.
Dupixent
February 17, 2026: Plaintiffs asked the Judicial Panel on Multidistrict Litigation (JPML) to centralize 15 lawsuits alleging the drug caused or worsened cutaneous T-cell lymphoma (CTCL).
December 23, 2025: A Georgia woman sued Regeneron, Sanofi, and Genzyme for allegedly concealing evidence linking the drug to CTCL.
Ethylene Oxide
January 23, 2026: The second bellwether trial in the District of Colorado proceeded with a single plaintiff, Bradley Schaak.
January 23, 2026: One of the two plaintiffs scheduled for the second bellwether trial dismissed his case with prejudice following a complete defense verdict in the first trial.
Hair Relaxer
March 2, 2026: Scheduled close of general causation expert discovery and expected court ruling on Bellwether Trial Case selection.
February 25, 2026: A Case Management Conference was held in Philadelphia Courts.
February 16, 2026: Deadline for the close of case-specific fact discovery and for parties to file position papers on trial selection.
January 20, 2026: Trial dates for Illinois state court cases and a Philadelphia Case Management Conference were scheduled.
January 8, 2026: Science day occured.
January 6, 2026: Defendants’ General Causation Expert Reports were due.
Hernia Mesh (Covidien)
February 17, 2026: The first bellwether trial was cancelled.
Lyft
February 20, 2026: A California federal judge ordered Lyft to produce background check and sexual misconduct records for four drivers who allegedly assaulted Uber passengers.
January 29, 2026: A JPML hearing was scheduled to decide if 17 federal lawsuits regarding driver sexual assaults should be centralized.
NEC Infant Formula
March 10, 2026: An Illinois jury heard opening arguments in a trial alleging Abbott’s Similac Special Care 24 caused necrotizing enterocolitis (NEC) in premature infants.
February 25, 2026: A Seventh Circuit panel showed skepticism over an Illinois federal court keeping several NEC cases in the MDL based on fraudulent joinder.
December 26, 2026: A Louisiana judge allowed design defect and failure-to-warn claims against Mead Johnson to proceed.
December 16, 2026: An Illinois appellate court ruled 23 lawsuits against Abbott were improperly filed in Cook County.
Paragard IUD
January 23, 2026: The first bellwether trial was in progress, with the judge severely criticizing Teva for making previously barred arguments during opening statements.
Paraquat
March 10, 2026: Syngenta announced it will stop global production of paraquat by June 2026 due to generic competition, though generic production ensures it will remain widely applied.
March 2, 2026: A follow-up conference on outstanding agenda items was scheduled in Philadelphia.
February 18, 2026: A Status Conference was held in the Philadelphia Court.
February 10, 2026: New York lawmakers introduced a bill to ban paraquat statewide citing links to Parkinson’s and cancers.
January 5, 2026: A Status conference took place.
PFAS
March 10, 2026: Alpena County, Michigan sued over a dozen chemical makers for soil and groundwater contamination at its regional airport.
March 3, 2026: The U.S. Supreme Court declined to review a ruling keeping lawsuits by Maryland and South Carolina in federal court.
February 23, 2026: The North Carolina Court of Appeals declined to review a public nuisance ruling against Chemours and DuPont, while companies in Georgia asked a judge to dismiss landowner suits for lack of standing.
February 11, 2026: Georgia lawmakers advanced a bill to limit PFAS liability for carpet and textile manufacturers.
February 10, 2026: Corteva and DuPont requested the disqualification of Mayer Brown in a New Jersey contamination lawsuit.
February 6, 2026: A contamination lawsuit by Fairfield, Connecticut moved forward in the South Carolina MDL.
January 23, 2026: The DC Circuit expressed skepticism toward industry challenges regarding the EPA’s designation of certain PFAS as hazardous.
January 16, 2026: 3M removed the Town of Fairfield’s lawsuit to federal court to assert federal contractor immunity.
December 10, 2026: The EPA proposed revising the TSCA PFAS reporting rule to add exemptions and reduce industry costs.
Powerport
March 10, 2026: An Arizona federal judge allowed defect and failure-to-warn claims to proceed to an April 21 bellwether trial.
January 12, 2026: The MDL judge allowed defense experts to testify that the medical benefits of Bard’s ports outweigh their risks.
Roblox
March 10, 2026: A Texas state judge ruled Roblox must face claims from the state’s Attorney General regarding misleading safety marketing.
March 6, 2026: Nebraska filed a lawsuit alleging Roblox failed to protect children from predators.
February 23, 2026: Los Angeles County filed a civil enforcement lawsuit against Roblox.
February 17, 2026: Plaintiffs proposed leadership attorneys for the MDL, and the Georgia Attorney General launched a child exploitation investigation into the platform.
February 10, 2026: Australia requested an urgent meeting over reports of child grooming on the platform.
February 5, 2026: A parent asked the Ninth Circuit to uphold a block on forced arbitration.
February 3, 2026: A California judge appointed co-lead counsel in the MDL.
December 15, 2026: The JPML centralized nearly 80 lawsuits in Northern California, and Florida sued the company for deceptive safety marketing.
Roundup
March 10, 2026: Kansas lawmakers considered a bill to block state lawsuits claiming pesticide makers failed to warn about cancer risks.
March 5, 2026: A Missouri court granted preliminary approval for a $7.25 billion nationwide class settlement.
February 25, 2026: Plaintiffs’ law firms requested a delay in reviewing Bayer’s proposed $7.25 billion settlement.
February 24, 2026: Monsanto asked the U.S. Supreme Court to overturn a $1.25 million failure-to-warn verdict in Missouri.
February 20, 2026: President Trump signed a Defense Production Act executive order to increase U.S. glyphosate production, citing national security.
February 18, 2026: Bayer shares dropped as investors doubted the $7.25 billion settlement would end legal issues.
February 17, 2026: Monsanto announced the $7.25 billion settlement to resolve current and future lymphoma claims.
January 16, 2026: The U.S. Supreme Court agreed to hear the Durnell preemption appeal regarding EPA labeling authority. (Hearings are scheduled for April 27, 2026).
January 13, 2026: Plaintiffs urged a New Jersey judge to allow 89 out-of-state claims, arguing Bayer runs its U.S. operations from a local “nerve center”.
Semaglutide
March 13, 2026: The FDA sent Novo Nordisk a warning letter for postmarketing adverse event reporting failures involving deaths and suicidal ideation.
March 9, 2026: A Status Conference was scheduled.
February 23, 2026: Deadline for Plaintiffs to serve rebuttal expert reports.
February 13, 2026: Deadline for Defendants to serve expert reports.
January 2, 2026: Deadline for Plaintiffs to serve expert reports.
December 2025: CMO 29 was posted, extending deadlines for cross-cutting issues.
Social Media Addiction
March 13, 2026: Closing arguments concluded in the first California bellwether trial. In the MDL, plaintiffs announced plans to seek sanctions against Meta for producing 73,000 late documents.
March 12, 2026: Meta and Google rested their defense in the JCCP bellwether trial.
March 11, 2026: A defense psychiatrist testified in the JCCP trial that the plaintiff was not addicted; Instagram head Adam Mosseri testified in the New Mexico trial.
March 10, 2026: A therapist testified in the JCCP trial, and Meta’s former head of integrity, Guy Rosen, testified in New Mexico.
March 9, 2026: A trust and safety expert testified for Meta in New Mexico; plaintiffs rested their case in the JCCP trial without calling the minor’s mother.
March 5-6, 2026: Mark Zuckerberg testified via video deposition in New Mexico, denying intentional habit-forming design; Meta began presenting its defense there. In the MDL, Meta requested a bench trial rather than a jury trial. A former Meta safety consultant testified in the JCCP trial that “addiction” became a taboo topic.
March 3-4, 2026: A UCLA psychiatrist defended her diagnosis of the JCCP plaintiff’s addiction. A Delaware judge ruled insurers have no duty to defend Meta. A Meta attorney accidentally revealed the JCCP plaintiff’s full name, prompting a judicial strike from the record.
February 24-27, 2026: Testimony continued in both JCCP and New Mexico trials covering excessive ad serving (17,000 ads), infinite scroll design, and internal encryption rollout warnings that hindered child exploitation detection.
February 23, 2026: Internal surveys showed 20% of users 13-15 saw unwanted nudity on Instagram; plaintiffs’ attorney Matthew Bergman was removed from the steering committee for filming in the courthouse.
February 17-20, 2026: Mark Zuckerberg and former Meta VP Brian Boland testified in the JCCP trial regarding tween user strategies and safety prioritization.
February 11, 2026: An MDL judge allowed negligence claims to proceed to a June 15 trial; Google argued in the JCCP trial that the plaintiff averaged only 29 minutes on YouTube.
February 9-10, 2026: New Mexico’s attorney general went to trial against Meta, and a jury was seated in the first California (JCCP) bellwether trial.
February 6, 2026: TikTok asked the North Carolina Supreme Court to dismiss a lawsuit citing lack of personal jurisdiction, while a California judge ordered Meta to provide accurate user time data.
January 15-23, 2026: Snapchat settled its first bellwether case. Meta failed to apply the crime-fraud exception to internal youth research documents and urged a judge to bar mentions of “Facemash” in trial.
December 8-18, 2025: 29 states sought a unified trial against Meta. Hawaii sued TikTok. The Massachusetts Supreme Judicial Court split on whether Meta is shielded by Section 230.
Talcum Powder
March 11, 2026: J&J urged the New Jersey Supreme Court to uphold Beasley Allen’s disqualification. A Virginia judge sanctioned a doctor for deleting emails relevant to a libel suit over a talc-mesothelioma article.
March 9, 2026: The New Jersey Supreme Court declined to pause the multicounty litigation while Beasley Allen appeals its disqualification.
March 3, 2026: A federal judge revived Pecos River Talc LLC’s trade libel suit against Dr. Jacqueline Moline.
February 23, 2026: A New Jersey judge refused to pause Beasley Allen’s disqualification order.
February 17, 2026: A Philadelphia jury awarded 250,000(50k compensatory, $200k punitive) to the estate of Gayle Emerson. Additionally, the Smith Law Firm sued investment firms over an alleged “loan-to-own” scheme.
February 9, 2026: An appeals court formally disqualified Beasley Allen from the J&J multicounty litigation due to ethics violations.
January 23, 2026: A special master cleared a major evidentiary hurdle, ruling plaintiffs’ experts may testify that genital talc use is causally linked to ovarian cancer.
January 14, 2026: J&J appealed to disqualify Beasley Allen over alleged shared confidential information.
December 22-23, 2025: Juries delivered massive verdicts against J&J: $65.5 million in Minnesota and over $1.5 billion to a single plaintiff in Baltimore.
December 12-15, 2025: A Los Angeles jury awarded $40 million against J&J in a bellwether ovarian cancer trial.
Uber / Rideshare
March 11-12, 2026: Uber asked a California judge to overturn an $8.5 million verdict and sought summary judgment in the broader MDL, arguing it is a technology platform and not a “common carrier” under North Carolina law.
February 18-20, 2026: A federal judge sanctioned a passengers’ attorney $30,000 for sharing confidential information. Uber announced it was tightening background checks after a NYT investigation revealed approvals of drivers with serious past convictions.
February 6, 2026: An Arizona jury found Uber liable under “apparent agency” for a driver’s sexual assault and awarded a rider $8.5 million in compensatory damages.
February 3, 2026: Uber’s chief product officer testified the company prioritized safety but “has not done enough”.
January 23, 2026: A magistrate judge warned a plaintiffs’ attorney regarding the misuse of MDL discovery materials as the first bellwether trial commenced.
December 10, 2025: A California judge expressed concern over an attorney’s “cavalier” handling of a protective order
